http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013510098-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-20 |
| filingDate | 2010-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2013510098-A |
| titleOfInvention | Specific crystalline hydrates, pharmaceutical compositions thereof, and methods of preparation and use thereof |
| abstract | At least one crystalline hydrate of (S)-[N-3- (3′-fluoro-4 ′-(4 ″ -phenylpiperazinyl)) phenyl-2-oxo-5-oxazolidinyl] methylacetamide; For example, having the following formula, where y is a number in the range 1/12 to 1. Also, a method for preparing such a crystalline hydrate, such a crystalline hydrate Also provided are pharmaceutical compositions comprising the same and methods of use thereof. |
| priorityDate | 2009-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 199.